In summary, these data suggest that knocking out cathepsin K deficiency mitigates diabetes-induced cardiac anomalies due to attenuation in calcineurin/NFAT signaling and subsequent reduction in cardiac oxidative stress and apoptosis. The gene discussed is CTSK; the disease is diabetes mellitus.